Cardiovascular Diseases

Earn up to 3 CPD points per module

Treating dyslipidaemia and hypertension – A practical clinical approach

Chronic illness and Ramadan fasting – Optimal management for patients intending to fast

Treating hypercholesterolaemia – too little, too late

Cardiometabolic syndrome – new approaches

Is lower better? LDL Cholesterol in perspective

Virtual CathLab – New learning facility for Africa

European Society of Cardiology (ESC) 2022

From science to clinical practice – lessons from REWIND

Protecting the cardiac patient post-MI

Rewinding cardiovascular risks

American College of Cardiology Update 2022

Recognising colchicine role in cardiovascular disease prevention

COVID-19 and Cardiovascular Disease

What’s new in atrial fibrillation?

COVID-19 and Thrombosis

New approaches to residual atherosclerosis risk

Fabry disease and the heart

Dyslipidaemia – getting to lower LDL targets safely

Current diagnosis and management of heart failure (HF) with reduced ejection fraction (HFrEF)

Angina: A missed medical opportunity

A new decade for patients with atrial fibrillation

From clinical hypothesis to a diagnosis of Fabry disease

American College of Cardiology Update 2021

Optimising patient care in atrial fibrillation

European Society of Cardiology (ESC) Congress 2021

Heart Failure – New Guidelines, New Treatments

Fabry Disease and the kidney

Heart failure update